• They also observed that in 28% of patients predicted to be sensitive to treatment, 3-year distant relapse-free survival (DRFS) was 92%, with a significant absolute risk reduction of 18%.

    研究者同时发现有28%的患者被预测为对治疗敏感,他们的3年无远处复发生存率为92%,绝对危险度大幅下降18%。

    youdao

  • We report a64-year-old man previously diagnosed with limited stage small cell lung cancer that presented with painless hematuria and arf after a2-year relapse-free period.

    我们报告一位六十四岁先前诊断为局限阶段小细胞肺癌的男性病人,经过两年无复发时期后,呈现出无痛性血尿和急性肾衰竭。

    youdao

  • She achieved a complete response and remains relapse-free 21months after her last dose of chemotherapy. Conclusion.

    患者获得了完全缓解并在末次化疗后的21个月持续无复发。

    youdao

  • She achieved a complete response and remains relapse-free 21months after her last dose of chemotherapy. Conclusion.

    患者获得了完全缓解并在末次化疗后的21个月持续无复发。

    youdao

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定